Skip to main content

Table 1 Clinical and biochemical characteristics and cardiac fat compartments in the study population

From: Cardiac steatosis and left ventricular function in men with metabolic syndrome

 

MetS present (n = 37)

MetS absent (n = 38)

p

Age (years)

47 ± 6

40 ± 8

<0.001

Body mass index (kg/m2)

30.9 (24.2-42.5)

23.4 (17.6-29.8)

<0.001

Waist circumference (cm)

107.0 (94.0-135.0)

87.0 (71.0-93.5)

<0.001

Height (cm)

180 ± 6

180 ± 6

0.665

Current smokers (N, %)

13 (35)

4 (10)

0.014

Systolic blood pressure (mmHg)

132 ± 14

115 ± 10

<0.001

Diastolic blood pressure (mmHg)

88 ± 9

74 ± 6

<0.001

Total cholesterol (mmol/L)

5.25 ± 0.74

4.38 ± 0.80

<0.001

Low-density lipoprotein cholesterol (mmol/L)

3.25 ± 0.71

2.52 ± 0.67

<0.001

High-density lipoprotein cholesterol (mmol/L)

1.02 ± 0.26

1.50 ± 0.40

<0.001

Triglycerides (mmol/L)

2.20 (0.65-6.26)

0.72 (0.35-1.57)

<0.001

fP-glucose (mmol/L)

5.8 (4.6-6.9)

5.0 (4.4-6.0)

<0.001

fS-insulin (mU/L)

9.3 (3.3-36.9)

2.9 (0.9-7.7)

<0.001

HOMA-IR index

2.6 (0.8-8.0)

0.6 (0.2-2.0)

<0.001

Myocardial triglyceride content (%)

0.90 (0.31-2.33)

0.43 (0.14-1.39)

<0.001

Epicardial fat (mm2)

838 (385-1753)

518 (251-1129)

<0.001

Pericardial fat (mm2)

1905 (615-6131)

562 (66-1582)

<0.001

  1. Data are expressed as means (± SD), medians (range), or frequencies (%). HOMA-IR, the homeostasis model assessment insulin resistance.